CNP PRODRUGS WITH CARRIER LINKAGE TO THE RING DEGREE

CY1125710T1Undetermined Publication Date: 2026-04-17ASCENDIS PHARMA GROWTH DISORDERS AS

0 Cites 0 Cited by

Patent Information

Application Number: CY20221100794T
Authority / Receiving Office: CY · CY
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2016-09-29
Filing Date: 2022-12-19
Publication Date: 2026-04-17
Estimated Expiration: 2042-12-19

Application Information

Patent Timeline

29 Sep 2016

Priority

19 Dec 2022

Application

CY20221100794T

17 Apr 2026

Publication

CY1125710T1

IPC: A61K47/60; A61P19/08

Inventors: RAU Harald; HERSEL Ulrich

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

AI Tagging

Technology Topics

Disease Pharmaceutical drug

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to CNP prodrugs in which the carrier is covalently and reversibly linked to the ring portion of a CNP moiety, to pharmaceutical compositions comprising these CNP prodrugs, to their uses, and to methods of treating diseases that can be treated therapeutically with the CNP prodrugs of the present invention.

Need to check novelty before this filing date? Find Prior Art